Related Experiment Video
Updated: May 18, 2026
05:22
Intracranial Cannula Implantation for Serial Locoregional Chimeric Antigen Receptor (CAR) T Cell Infusions in Mice
Published on: February 24, 2023
Navigating cancer network attractors for tumor-specific therapy
Pau Creixell1, Erwin M Schoof, Janine T Erler
1Cellular Signal Integration Group (C-SIG), Center for Biological Sequence Analysis (CBS), Department of Systems Biology, Technical University of Denmark (DTU), Lyngby, Denmark.
Nature Biotechnology
|September 12, 2012
Summary
Cancer cells shift to malignant states via network attractors, driven by molecular changes. Understanding these cancer network dynamics is key for developing targeted therapies against drug resistance and metastasis.
Area of Science:
- Systems biology
- Cancer biology
- Network science
Background:
- Cellular signaling networks are dynamic and crucial for biological decisions.
- Aberrant signaling networks can lead cells to malignant states (cancer network attractors).
- Diverse molecular alterations drive different cancer cells toward these malignant states.
Purpose of the Study:
- To explore systems-based strategies for understanding cancer signaling networks.
- To investigate how genetic lesions perturb networks and cause disease phenotypes.
- To identify mechanisms underlying cancer development and progression.
Main Methods:
- Analysis of dynamic cellular signaling networks.
- Systems-based approaches to model cancer network attractors.
- Investigating molecular alterations and their impact on network properties.
Main Results:
- Cancer development involves cells entering malignant signaling and phenotypic states.
- Uncovering the mechanisms of network perturbations in cancer is a significant challenge.
- Network biology offers insights into cancer complexity.
Conclusions:
- Systems-based strategies are needed to understand cancer signaling network perturbations.
- Network biology can reveal how genetic lesions drive cancer phenotypes.
- This approach can advance personalized and tumor-specific cancer therapies, overcoming drug resistance and metastasis.
Related Concept Videos
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
02:53Adaptive Mechanisms in Cancer Cells
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...